Original Research
Published on 17 Jul 2019
The Natural Compound Neobractatin Induces Cell Cycle Arrest by Regulating E2F1 and Gadd45α
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.00654
- 5,710 views
- 11 citations
Type at least 3 characters
1,011 articles
Articles
Original Research
Published on 12 Jul 2019
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection With Transcriptome Analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.00632
- 5,944 views
- 24 citations
Review
Published on 10 Jul 2019
Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.00626
- 19,248 views
- 162 citations
Case Report
Published on 09 Jul 2019
Trabectedin Drug Holiday and Rechallenge in Soft Tissue Sarcomas: Report of 4 Cases and Literature Review
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.00553
- 4,938 views
- 4 citations
Original Research
Published on 04 Jul 2019
Folic Acid Receptor-Mediated Targeting Enhances the Cytotoxicity, Efficacy, and Selectivity of Withania somnifera Leaf Extract: In vitro and in vivo Evidence
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.00602
- 7,571 views
- 33 citations
Original Research
Published on 04 Jul 2019
Antitumor Effects and Related Mechanisms of Ethyl Acetate Extracts of Polygonum perfoliatum L.
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.00578
- 4,016 views
- 7 citations
Original Research
Published on 03 Jul 2019
Ruthenium Complexes With Piplartine Cause Apoptosis Through MAPK Signaling by a p53-Dependent Pathway in Human Colon Carcinoma Cells and Inhibit Tumor Development in a Xenograft Model
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.00582
- 3,982 views
- 20 citations
Original Research
Published on 26 Jun 2019
Rotundic Acid Induces DNA Damage and Cell Death in Hepatocellular Carcinoma Through AKT/mTOR and MAPK Pathways
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.00545
- 4,613 views
- 20 citations
Review
Published on 21 Jun 2019
Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in Hepatocarcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.00541
- 44,321 views
- 395 citations
Original Research
Published on 14 Jun 2019
Ursolic Acid Reverses the Chemoresistance of Breast Cancer Cells to Paclitaxel by Targeting MiRNA-149-5p/MyD88
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.00501
- 5,327 views
- 55 citations
Original Research
Published on 13 Jun 2019
Catechins-Modified Selenium-Doped Hydroxyapatite Nanomaterials for Improved Osteosarcoma Therapy Through Generation of Reactive Oxygen Species
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.00499
- 5,600 views
- 47 citations
Review
Published on 12 Jun 2019
Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.00487
- 23,434 views
- 116 citations
Original Research
Published on 11 Jun 2019
C8-Substituted Imidazotetrazine Analogs Overcome Temozolomide Resistance by Inducing DNA Adducts and DNA Damage
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.00485
- 4,573 views
- 19 citations
Mini Review
Published on 04 Jun 2019
Analysis of Survival Curves: Statistical Methods Accounting for the Presence of Long-Term Survivors
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.00453
- 27,211 views
- 30 citations
Original Research
Published on 04 Jun 2019
CAPE-pNO2 Inhibited the Growth and Metastasis of Triple-Negative Breast Cancer via the EGFR/STAT3/Akt/E-Cadherin Signaling Pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.00461
- 4,996 views
- 33 citations
Original Research
Published on 29 May 2019
p53-Dependent Anti-Proliferative and Pro-Apoptotic Effects of a Gold(I) N-Heterocyclic Carbene (NHC) Complex in Colorectal Cancer Cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.00438
- 6,572 views
- 37 citations